ONCOZENGE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.635 SEK | +4.15% |
|
-2.02% | +17.64% |
| 21/05 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 08/04 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOZENGE AB | Other Pharmaceuticals | +4.15% | -2.02% | +17.64% | -45.83% | - | 3.81M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ONCOZ Stock
- Charts OncoZenge AB
- Comparison Chart
